Cytokine induction after Epstein-Barr virus infection of peripheral T-lymphocytes in vitro

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields Virology, 5th ed. Philadelphia:Lippincott Williams and Wilkins; 2007. p. 2655-99.Search in Google Scholar

2. Cohen JI. Virology and molecular biology of Epstein- Barr virus. In: Tselis A, Jenson HB, eds. Epstein-Barr virus. New York:Taylor & Francis group; 2006. p. 21-37.10.3109/9781420014280.002Search in Google Scholar

3. Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, eds. Fields Virology, 5th ed. Philadelphia:Lippincott Williams and Wilkins; 2007. p. 2603-54.Search in Google Scholar

4. Chen C, Sadler RH, Walling DM, Su I, Hsieh H, Raab- Traub N. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol. 1993; 67:6303-8.10.1128/jvi.67.10.6303-6308.1993Search in Google Scholar

5. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997; 100:1969-79.10.1172/JCI1197285083869329960Open DOISearch in Google Scholar

6. Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, et al. Epstein-Barr virusassociated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic and molecular analysis. Am J Hematol. 2002; 70:31-8.10.1002/ajh.1009411994979Search in Google Scholar

7. Mitarnun W, Pradutkanchana J, Takao S, Saechan V, Suwiwat S, Ishida T. Epstein-Barr virus-associated non-Hodgkin’s lymphoma of B-cell origin, Hodgkin’s disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis. J Med Assoc Thai. 2002; 85:552-9.Search in Google Scholar

8. Mitarnun W, Saechan V, Suwiwat S, Pradutkanchana J, Takao S, Ishida T. Hepatic T-cell infiltrates in patients with peripheral T-cell proliferative disease/ lymphomas: clinicopathologic and molecular analysis. Pathol Int. 2004; 54:819-29.10.1111/j.1440-1827.2004.01766.x15533224Search in Google Scholar

9. Mitarnun W, Suwiwat S, Pradutkanchana J. Epstein- Barr virus-associated extranodal non-Hodgkin’s lymphoma of the sinonasal tract and nasopharynx in Thailand. Asian Pac J Cancer Prev. 2006; 7:91-4.Search in Google Scholar

10. Suwiwat S, Pradutkanchana J, Ishida T, Mitarnun W. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T cell proliferative diseases. J Clin Virol. 2007; 40:277-83.10.1016/j.jcv.2007.08.01317996493Search in Google Scholar

11. Guan M, Zhang RD, Wu B, Henderson EE. Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression. J Virol. 1996; 70:7341-6.10.1128/jvi.70.10.7341-7346.19961908018794395Search in Google Scholar

12. Guan M, Romano G, Henderson EE. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes. Anticancer Res. 1998; 18:3171-80.Search in Google Scholar

13. Paterson RL, Kelleher CA, Streib JE, Amankonah TD, Xu JW, Jones JF, Gelfand EW. Activation of human thymocytes after infection by EBV. J Immunol. 1995; 154:1440-9.10.4049/jimmunol.154.3.1440Search in Google Scholar

14. Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Xu JW, Takase K, et al. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF- 1 and its repressor RAZ. Virology. 1995; 208:685-95. 10.1006/viro.1995.12007747440Search in Google Scholar

15. Ninla-aesong P, Pradutkanchana J, Noipha K, Mitarnun W. Lytic Replication of Epstein-Barr Virus in Human Peripheral T-Lymphocytes. Asian Biomed. 2010; 4: (in press).10.2478/abm-2010-0028Search in Google Scholar

16. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, et al. Infection of human thymocytes by Epstein-Barr virus. J Exp Med. 1991; 173:971-80. 10.1084/jem.173.4.97121908011706754Search in Google Scholar

17. D’Addario M, Ahmad A, Morgan A, Menezes J. Binding of Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-a gene expression in monocytic cells via NF-KB involving PKC, PI3-K and tyrosine kinases. J Mol Biol. 2000; 298:765-78.10.1006/jmbi.2000.3717Search in Google Scholar

18. Gruffat H, Batisse J, Pich D, Neuhierl B, Manet E, Hammerschmidt W, et al. Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J Virol. 2002; 76:9635-44.10.1128/JVI.76.19.9635-9644.2002Open DOISearch in Google Scholar

19. Savard M, Belanger C, Tardif M, Gourde P, Flamand L, Gosselin J. Infection of primary human monocytes by Epstein-Barr virus. J Virol. 2000; 74:2612-9.10.1128/JVI.74.6.2612-2619.2000Open DOISearch in Google Scholar

20. Moir S, Malaspina A, Ogwaro KM, Donoghue ET, Hallahan CW, Ehler LA, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci USA. 2001; 98:10362-7.10.1073/pnas.181347898Search in Google Scholar

21. Mori A, Takao S, Pradutkanchana S, Kiettubthew S, Mitarnun W, Ishida T. High tumor necrosis factorlevels in the patients with Epstein-Barr virusassociated peripheral T-cell proliferative disease/ lymphoma. Leuk Res. 2003; 27:493-8.10.1016/S0145-2126(02)00266-7Search in Google Scholar

22. Dutcher JP. The role of Epstein-Barr virus and elevated levels of tumor necrosis factor in determining prognosis in Asian peripheral T-cell lymphomas. Leuk Res. 2003; 27:467-9.10.1016/S0145-2126(02)00274-6Search in Google Scholar

23. Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. J Immunol. 1986; 136:3636-42.10.4049/jimmunol.136.10.3636Search in Google Scholar

24. Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, et al. Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Cell Microbiol. 2007; 9:2055-69.10.1111/j.1462-5822.2007.00937.x17419714Open DOISearch in Google Scholar

25. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-a gene expression. J Clin Invest. 1994; 93:474-8.10.1172/JCI1169952938608113386Search in Google Scholar

26. Iwamoto GK, Konicek SA. Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression. J Investig Med. 1997; 45:175-82.Search in Google Scholar

27. Stein J, Volk H-D, Liebenthal C, Krtiger DH, PrOsch S. Tumor necrosis factor-a stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol. 1993; 74:2333-8.10.1099/0022-1317-74-11-23338245850Search in Google Scholar

28. Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD. The Zta transactivator involved in induction of lytic cycle gene expression in Epstein- Barr virus infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol. 1990; 64:1143-55.10.1128/jvi.64.3.1143-1155.19902492282154599Search in Google Scholar

29. Cayrol C, Flemington EK. Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: Activation of transforming growth factor IGH3 (TGF-bIGH3) and TGF-1. J Virol. 1995; 69:4206-12.10.1128/jvi.69.7.4206-4212.1995Search in Google Scholar

30. Han JS, Choi BS, Yang CW, Kim YS. Aldosteroneinduced TGF-beta1 expression is regulated by mitogen-activated protein kinases and activator protein-1 in mesangial cells. J Korean Med Sci. 2009; 24 (Suppl): S195-203.10.3346/jkms.2009.24.S1.S195263317819194552Search in Google Scholar